• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Athenahealth roiled by earnings postponement

Athenahealth roiled by earnings postponement

February 26, 2010 By MassDevice staff

Athenahealth Inc. (NSDQ:ATHN) is taking its lumps from investors and analysts after postponing a scheduled earnings announcement while company officials work to complete a year-end audit and internal accounting policy review.

In announcing the delay, executives with the Watertown, Mass.-based provider of web-based processing of insurance claims for physician practices did not indicate when they expect to complete the review. They said the company would be filing documentation with the federal Securities & Exchange Commission next week, seeking an additional five days before issuing its financial results for the three months and fiscal year ended Dec. 31, 2009.

The company already had been experiencing some upheaval connected with its accounting. It announced on Jan. 11 that Timothy Adams had been appointed as its new chief financial officer, replacing Carl Byers, who had been in that position at Athenahealth since its 1997 founding. Byers said last summer he planned to step down in early 2010 but was planning to stay on as an advisor to the company.

Athenahealth earlier this month also said it was changing the way it would account for its non-GAAP adjusted net income.

Several analysts were quick to downgrade the company’s stock, which on Feb. 26 opened down $5 a share, or about 12 percent, from its previous close. Through the first hour of trading, volume was about six times the stock’s activity for a full session. Robert W. Baird and JMP Securities dropped their respective outlooks for the stock, with JMP lowering its rating for Athenahealth from “Outperform” to “Market Perform” while Baird reduced its rating from “Outperform” to “Neutral.”

In a statement Feb. 25, Athenahealth said its accounting review “related to the timing of amortization for deferred implementation revenue.” Through the first nine months of 2009, the company had reported nearly $7.6 million in implementation and other revenues, or about 5.5 percent of the company’s total revenues for the period.

According to recent financial statements, implementation revenues largely consist of “professional services fees related to assisting clients with the implementation of our services and for ongoing training and related support services.”

Through Sept. 30, Athenahealth reported total revenues of $137.5 million.

Filed Under: Business/Financial News, News Well Tagged With: Athenahealth Inc., Insurance

More recent news

  • Mount Sinai adopts Flosonics wearable ultrasound device
  • GE HealthCare launches next-gen intraoperative ultrasound
  • Philips launches new point-of-care ultrasound system
  • Medtronic to invest $50M in India Diabetes center
  • Corvia Medical raises $55M as it seeks FDA nod for atrial shunt

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy